Aytu Biopharma (AYTU) Capital Expenditures Growth (1y) (2016 - 2025)
Aytu Biopharma (AYTU) Capital Expenditures Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.39 Bn | 39.74 Bn | 2.15 Bn | 8.33% |
| 3 | Zoetis | 31.86 Bn | 30.18 Bn | 1.05 Bn | -19.86% |
| 4 | Takeda Pharmaceutical | 28.78 Bn | 22.99 Bn | 5.10 Bn | -1.95% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 73.63% |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | -0.19% |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -37.60% |
| 8 | Elanco Animal Health | 11.92 Bn | 11.39 Bn | 798.00 Mn | -42.11% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 9.99 Bn | - | - |
| 10 | Aytu Biopharma | 24.75 Mn | -1.96 Mn | 7.60 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 183.33% |
| Jun 30, 2025 | -94.83% |
| Jun 30, 2021 | -123.21% |
| Jun 30, 2020 | -1,429.09% |
| Mar 31, 2020 | 282.39% |
| Dec 31, 2019 | 466.80% |
| Mar 31, 2019 | -1,284.02% |
| Mar 31, 2018 | -91.13% |
| Mar 31, 2017 | 309.59% |
| Dec 31, 2016 | -184.28% |